These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion. Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436 [TBL] [Abstract][Full Text] [Related]
9. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [TBL] [Abstract][Full Text] [Related]
10. Proliferation signal inhibitors and cardiac allograft vasculopathy. Raichlin E; Kushwaha SS Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540 [TBL] [Abstract][Full Text] [Related]
11. Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy. Chapman JR; Valantine H; Albanell J; Arns WA; Campistol JM; Eisen H; Frigerio M; Lehmkuhl H; Marcen R; Morris R; Nashan B; Pascual J; Pohanka E; Segovia J; Zuckermann A Transplant Proc; 2007 Dec; 39(10):2937-50. PubMed ID: 18089298 [TBL] [Abstract][Full Text] [Related]
12. Can mTOR inhibitors reduce the risk of late kidney allograft failure? Ponticelli C Transpl Int; 2008 Jan; 21(1):2-10. PubMed ID: 17635837 [TBL] [Abstract][Full Text] [Related]
13. Chronic renal allograft injury: early detection, accurate diagnosis and management. Pascual J; Pérez-Sáez MJ; Mir M; Crespo M Transplant Rev (Orlando); 2012 Oct; 26(4):280-90. PubMed ID: 22902496 [TBL] [Abstract][Full Text] [Related]
14. [Proliferation signal inhibitors: what therapeutic protocols are followed in 2009?]. Ladrière M Nephrol Ther; 2009 Dec; 5 Suppl 6():S385-9. PubMed ID: 20129450 [TBL] [Abstract][Full Text] [Related]
19. Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure. Carmellini M; Collini A; Ruggieri G; Garosi G; Bernini M Transplant Proc; 2008; 40(6):1858-61. PubMed ID: 18675070 [TBL] [Abstract][Full Text] [Related]
20. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation. de Fijter JW Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i23-6. PubMed ID: 17456615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]